OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
February 02, 2017
Although limitations must be overcome, mass spectrometry is having a great impact on biologic development and manufacturing.
February 01, 2017
FDA issued approvals for less than half the number of new drugs in 2016 compared with 2015.
January 04, 2017
Alternatives to expensive palladium catalysts are gaining acceptance for commercial API synthesis.
January 02, 2017
As of mid-December, less than half the number of new drug approvals were issued by FDA in 2016 compared with 2015.
December 07, 2016
Previous hesitation by pharma industry to use cocrystals may change with FDA’s new guidance that classifies cocrystals APIs.
December 02, 2016
Non-precious-metal catalysts are increasingly employed for commercial API synthesis.